Core Viewpoint - The company has experienced abnormal stock trading fluctuations, with a cumulative closing price increase of 20% over three consecutive trading days, prompting the need for disclosure and clarification regarding its operational status and any undisclosed significant information [1][4]. Group 1: Company Operational Status - The company and its subsidiaries are operating normally, with no significant changes in the market environment or industry policies [2]. - The company has confirmed with its controlling shareholder, Qingdao Zhican, that there are no undisclosed significant matters, including major asset restructuring or significant transactions [2][3]. - No media reports or market rumors have been identified that could impact the company's stock trading price [2]. Group 2: Risks and Uncertainties - The company is investing in a computing power service business, which involves substantial capital investment and is subject to various uncertainties, including macroeconomic conditions and industry competition [3]. - There is uncertainty regarding the performance of compensation obligations due to the judicial freeze on shares held by key individuals, which may affect the company's ability to recover compensation [3][4]. - Financial investors have significantly reduced their holdings, with a total of 962,311,324 shares sold, representing 81.80% of their previously acquired shares, which may continue to impact stock performance [4]. Group 3: Stock Trading Fluctuations - The company's stock experienced a significant price deviation, with a cumulative increase of 20% over three trading days, indicating substantial volatility in the secondary market [1][4]. - Investors are advised to exercise caution and make rational investment decisions in light of the observed trading risks [4]. Group 4: Board Statement - The company's board confirms that there are no undisclosed matters that should have been reported according to the relevant stock exchange rules, and all previously disclosed information remains accurate [4].
奥瑞德: 奥瑞德股票交易异常波动公告